Boston Therapeutics Appoints Benjamin Rivnay as Chief Scientist [Professional Services Close - Up]
(Professional Services Close - Up Via Acquire Media NewsEdge) Boston Therapeutics has tapped Benjamin Rivnay to serve as its Chief Scientist, a newly created position.
According to a company release, Rivnay will serve as the primary liaison to the Company's Medical Advisory Board and report to Rom Eliaz, chairman of the Board of Directors' Scientific Advisory Committee.
Most recently, he was Director of Research and Development at Formatech.
David Platt, Chief Executive Officer of Boston Therapeutics, said, "We are truly fortunate that Benjamin Rivnay, with his impressive breadth of experience, has chosen to join the Company as Chief Scientist. His professional background ideally places him to oversee our anticipated growth in research, science and technological innovations through the coming years. We anticipate that his insights will drive us to further success as an innovator in the diabetes market."
((Comments on this story may be sent to email@example.com))
(c) 2014 ProQuest Information and Learning Company; All Rights Reserved.
[ Back To Cloud Contact Center's Homepage ]